BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Riverain Technologies Receives CE Mark for ClearRead +Confirm™


11/26/2012 7:24:53 AM

DAYTON, Ohio--(BUSINESS WIRE)-- New software by Riverain Technologies that improves the visual clarity of conventional chest X-ray images and increases radiologists’ efficiency by reducing the time it takes to accurately confirm the proper placement of lifesaving feeding, drug-delivery and pain management tubes and lines has received CE Mark approval.

The software, ClearRead +Confirm™, will be introduced at the 2012 Radiological Society of North America (RSNA) annual meeting in Chicago.

Tubes and lines placed inside the body are used regularly for intensive care patients and others receiving ongoing treatments for cancer, pain and other conditions. Improper placement or migration of the devices between uses can cause serious complications, including death.

Portable chest X-ray machines are routinely used to confirm placement of lines and tubes; however, the image quality makes it challenging for radiologists to differentiate these structures, and the rib and clavicle bones obscure visibility of chest tissue by up to 40 percent. Radiologists also incur significant time adjusting the image to make the edges and tips of the devices stand out.

ClearRead +Confirm™ software immediately processes any portable chest X-ray, creating a second, soft tissue image with the ribs and clavicles suppressed and increasing the contrast, sharpness and visibility of tubes, lines and cardiac wires. Radiologists simply toggle between the two images to confidently and efficiently confirm proper placement of the devices.

A Georgetown University reader study assessed the time it took radiologists to locate:

PICC lines, or peripherally inserted central catheters, which are long, thin tubes that remain inside the chest to deliver nutrients, fluid, blood, and medicines over time to treat pain, infection or cancer. PICC lines also are used to draw blood samples and provide kidney dialysis.

Nasogastric tubes (NG tubes), which carry food and medicine to the stomach through the nose.

Wires that conduct or measure electrical impulses, including electrodes for cardiac pacing and defibrillation.

In the study, 334 chest X-rays were reviewed by 10 radiologists with and without the enhanced ClearRead +Confirm image. The software reduced the reading time by an average of nearly 19 percent, without comprising accuracy.

Evaluating the conventional X-ray and ClearRead image together took an average of 5 ½ seconds less per image than evaluating the conventional X-ray image on its own, amounting to a savings of 30 minutes across all images.

Participating radiologists strongly agreed that the enhanced image increased their confidence in confirming the placement of lines and tubes and made it easier to see venous catheters.

“The software-enhanced chest X-ray image increases radiologists’ confidence while reducing decision-making time and time to treatment, with no additional tests or radiation exposure for patients,” said Steve Worrell, Riverain’s Chief Technology Officer.

ClearRead +Confirm uses the clinically proven, proprietary machine learning and pattern recognition technologies in Riverain’s chest X-ray bone-suppression and computer-aided detection (CAD) software.

ClearRead +Confirm software is cleared for sale in Europe and is currently being reviewed for clearance by the FDA.

For a demonstration or additional information, visit the Riverain Technologies booth at RSNA 2012 (#5917, South Building, Hall A) or www.RiverainTechnologies.com.

Riverain Technologies

An industry leader and technology innovator, Riverain Technologies applies proprietary pattern recognition and machine learning technologies in the creation of software applications for use globally in the health care industry and beyond. The Ohio-based company has developed practical solutions to save and improve the quality of people’s lives through the early detection of disease. The company’s ClearRead software enhances the expert skills of radiologists to improve patient outcomes using standard chest X-ray, without additional radiation dose or procedures for patients. For more information please visit www.RiverainTechnologies.com.

Contact:

PCI

Marissa Ellenby, 312-558-1770

mellenby@pcipr.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES